The Melanoma Research Alliance (MRA), the world's leading non-profit funder of melanoma research, has successfully a raised a sum of $9.3 million investment to drive cutting-edge melanoma...
Alkermes has officially published the results from a new survey, which was designed to understand utilization of and experiences with treatment among 300 adults between aged 21-64...
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, has officially announced...
Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, has officially raised a sum worth $30...
Simulations Plus, Inc., a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, has officially extended its support of...
Johnson & Johnson is officially set to showcase new data from its leading oncology pipeline at the American Urological Association 2025 Annual Meeting.
According to certain reports, the...
The Lupus Research Alliance (LRA) has officially announced the recipients of this year's Lupus Innovation Award (LIA), an award which acknowledges industry-wide efforts to address several critical...
WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, has officially announced the launch of WCG ClinSphere™ Total Feasibility's Software-as-a-Service (SaaS) technology...
Lumen has officially published top-line results from the sentinel cohort of its RePreve Clinical Trial which evaluated LMN-201 for Clostridioides difficile infection (CDI).
In case you weren't aware,...
